SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

Communiqués Shin Nippon Biomedical Laboratories, Ltd. BOERSE MUENCHEN

Actions

YB3

JP3379950003

Marché Fermé - BOERSE MUENCHEN Autres places de cotation 21:43:13 03/07/2024			Varia. 5j.	Varia. 1 janv.
8 ^EUR	0,00 %		-3,61 %	-25,93 %

08/05	Shin Nippon Biomedical Laboratories, Ltd. annonce un dividende de fin d'exercice pour l'exercice fiscal clôturé le 31 mars 2024, payable le 25 juin 2024 ; donne des indications sur la fin du deuxième trimestre et le dividende de fin d'exercice pour l'exercice fiscal clôturé le 31 mars 2025	CI
08/05	Shin Nippon Biomedical Laboratories, Ltd. présente ses prévisions de résultats consolidés pour le semestre se terminant le 30 septembre 2024 et l'année se terminant le 31 mars 2025	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Shin Nippon Biomedical Laboratories : 英語版株主通信（2023/04/01~2023/09/30）を発行しました	27/12	PU
Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be presented at the American Headache Society's 65th Annual Scientific Meeting	16/06/23	AQ
Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific Meeting	15/06/23	AQ
Shin Nippon Biomedical Laboratories : Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2023 (Under Japanese GAAP)	29/07/22	PU
Shin Nippon Biomedical Laboratories : Presentation materials for the First Three Months of the Fiscal Year Ending March 31, 2023	29/07/22	PU
Shin Nippon Biomedical Laboratories : Notice Regarding Revisions of the Earnings Forecasts for the Six Months and Full-Year of the Fiscal Year Ending March 31, 2023	29/07/22	PU
Shin Nippon Biomedical Laboratories : Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2022 (Under Japanese GAAP)	02/02/22	PU
Shin Nippon Biomedical Laboratories : Notice Regarding Revisions of Consolidated Earnings and Dividend Forecasts for the Full-Year of the Fiscal Year Ending March 31,2022	02/02/22	PU
Shin Nippon Biomedical Laboratories : Supplementary Material on Quarterly Financial Results	02/02/22	PU
Supplementary Material on 1H Financial Results	04/11/21	PU
Shin Nippon Biomedical Laboratories : Notice Regarding Revisions of the Earnings Forecasts for the Six Months and Full Year of the Fiscal Year Ending March 31, 2022	21/10/21	PU
Shin Nippon Biomedical Laboratories : Notice Regarding Establishment of SDGs Committee	27/08/21	PU
Shin Nippon Biomedical Laboratories : Health & Productivity Award 2019	27/02/19	PU
Shin Nippon Biomedical Laboratories : SNBL will give a preclinical seminar in Taiwan	18/01/19	PU
Shin Nippon Biomedical Laboratories : 2018 Prime Minister's Award	21/12/18	PU
Shin Nippon Biomedical Laboratories : MHLW Award of Excellence	03/12/18	PU
Shin Nippon Biomedical Laboratories : Conclusion of Memorandum of Understanding with Medgaea Life Sciences Ltd. for Cooperative Relationship	29/08/18	PU
Shin Nippon Biomedical Laboratories : Investment in Trunk Solution Corporation (TSC)	03/08/18	PU
Shin Nippon Biomedical Laboratories : Wings of Dreams	24/07/18	PU
Shin Nippon Biomedical Laboratories : Another Ophthalmologist	08/05/18	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Shin Nippon Biomedical Laboratories, Ltd. BOERSE MUENCHEN

Actions

YB3

JP3379950003

Communiqués

Filtres